Holen Sie sich die Stockscreener-App
55.41
0.47%
-0.26
Vorhandelsmarkt:
57.26
1.85
+3.34%
Scholar Rock Holding Corp Aktie (SRRK) Neueste Nachrichten
SRRK Shares Surge 12% After FDA Approval of Isembyld for Spinal Muscular Atrophy - GuruFocus
SRRK Stock Gains After Company Drops Troubled Novo Nordisk-Owned Plant From FDA Filing - Stocktwits
symbol__ Stock Quote Price and Forecast - CNN
Second Time’s The Charm: FDA Clears Scholar Rock’s SMA Drug Ahead Of Deadline, SRRK Soars 15% After-Hours - Stocktwits
Scholar Rock (SRRK) Gains FDA Approval for Isembyld Amid High Pr - GuruFocus
FDA Approves Isembyld (apitegromab-mstn), the First and Only Muscle-Targeted Therapy for Spinal Muscular Atrophy, Marking a New Milestone in SMA Treatment - GlobeNewswire Inc.
Scholar Rock at citigroup biopharma summit: FDA decision nears By Investing.com - Investing.com Nigeria
BMO reiterates Scholar Rock stock Outperform on SMA drug uptake - Investing.com
BMO reiterates Scholar Rock stock Outperform on SMA drug uptake By Investing.com - Investing.com India
Scholar Rock at citigroup biopharma summit: FDA decision nears - Investing.com
Scholar Rock Holding Corporation $SRRK Stock Position Lifted by Squarepoint Ops LLC - MarketBeat
Scholar Rock at cantor global healthcare conference: approval clock nears By Investing.com - Investing.com South Africa
SRRK Reiterates by HC Wainwright & Co. -- Price Target Maintained at $65 - GuruFocus
Scholar Rock's (SRRK) Buy Rating Reaffirmed at HC Wainwright - MarketBeat
Legal & General Group Plc Invests $3.36 Million in Scholar Rock Holding Corporation $SRRK - MarketBeat
Scholar Rock (SRRK) Gains FDA Fast Track for Apitegromab Amid Hi - GuruFocus
122,223 Shares in Scholar Rock Holding Corporation $SRRK Acquired by The Manufacturers Life Insurance Company - marketbeat.com
Beaconlight Capital LLC Makes New Investment in Scholar Rock Holding Corporation $SRRK - MarketBeat
Scholar Rock Holding (SRRK) Stock Dropped, So What Is Behind The Latest Attention? - simplywall.st
Bank of New York Mellon Corp Acquires New Shares in Scholar Rock Holding Corporation $SRRK - MarketBeat
104,346 Shares in Scholar Rock Holding Corporation $SRRK Acquired by Man Group plc - MarketBeat
Algert Global LLC Grows Stock Holdings in Scholar Rock Holding Corporation $SRRK - MarketBeat
Jupiter Topco LLC Invests $123.28 Million in Scholar Rock Holding Corporation $SRRK - MarketBeat
Scholar Rock (NASDAQ:SRRK) Shares Up 5.8%Still a Buy? - MarketBeat
Nicholas Investment Partners LP Purchases New Position in Scholar Rock Holding Corporation $SRRK - MarketBeat
9,494,084 Shares in Scholar Rock Holding Corporation $SRRK Purchased by BlackRock Inc. - marketbeat.com
Scholar Rock Holding Corp stock hits 52-week high at 58.52 USD - Investing.com Canada
Scholar Rock (SRRK) Is Up 8.5% After De-Risking Apitegromab’s Global Filing PathwayHas The Bull Case Changed? - sahmcapital.com
Scholar Rock (SRRK) Stock Trades At A Premium As Its 8x Run Continues - simplywall.st
Scholar Rock (SRRK) Streamlines Apitegromab Filings After Catalent Shift Is Regulatory Strategy De-Risking The Story? - Yahoo Finance
Scholar Rock withdraws Europe filing for muscle weakness drug, plans resubmission - Reuters
Scholar Rock (NASDAQ:SRRK): Healthcare Milestone Draws Focus - Kalkine Media
Scholar Rock advances apitegromab FDA review - grafa.com
Scholar Rock removes Catalent facility from SMA drug application By Investing.com - Investing.com Canada
Scholar Rock is prepared to launch its SMA drug if FDA approves by Sept. 30 - Stock Titan
Eagle Health Investments LP Invests $30.54 Million in Scholar Rock Holding Corporation $SRRK - MarketBeat
Scholar Rock Holding Corporation (NASDAQ:SRRK) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat
Scholar Rock Holding (SRRK) After Apitegromab Progress Is The Stock Already Fully Valued - Sahm
Scholar Rock Eyes Sept. 30 FDA Decision for SMA Drug Apitegromab - MarketBeat
How Investors Are Reacting To Scholar Rock (SRRK) Dual Fill-Finish Readiness Amid Ongoing FDA Review - simplywall.st
Is Scholar Rock Holding Corporation (SRRK) Better Positioned than Novo Nordisk A/S (NVO) After Recent Setbacks? - Yahoo Finance
Redmile Group (SRRK) updates Scholar Rock stake to 3.6% of common stock - Stock Titan
12 New Hires Receive 51,947 Scholar Rock Equity Awards - Stock Titan
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
SRRK Stock Surges To Near Five-Year Highs – Here’s Why Analysts Are Bullish About Its Latest FDA Filing - Stocktwits
Scholar Rock (SRRK) Stock Looks Priced At A Premium Today - simplywall.st
SRRK Maintains by JP Morgan -- Price Target Raised to $63.00 - GuruFocus
Scholar Rock (NASDAQ:SRRK) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says - MarketBeat
Invus reports 8.0% stake in Scholar Rock (SRRK) through 9.6M shares - Stock Titan
SRRK Stock Prediction: Huge SMA Drug Launch Breakthrough? (2026 Alert) The Rock (yAPbDwyblt) - Mshale
Scholar Rock at canaccord growth conference: approval path narrows By Investing.com - Investing.com Canada
Scholar Rock at canaccord growth conference: approval path narrows - Investing.com India
Scholar Rock Overcomes Manufacturing Hurdle to Keep Lead Drug FDA Review on Schedule - Sahm
0.24%
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):